Product Images Risedronate Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 13 images provide visual information about the product associated with Risedronate Sodium NDC 65862-519 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - risedronate fig1

Figure 1 - risedronate fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 30 mg Blister Carton (10 x 10 Unit Dose) - risedronate fig10

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 30 mg Blister Carton (10 x 10 Unit Dose) - risedronate fig10

This is information about a medication called Risedronate Sodium Tablets. The National Drug Code (NDC) for this medication is 65862-518-78. It is a prescription medicine. The medication guide for patients is included and should be given to each patient who receives the medicine. The tablets are manufactured by Aurobindo and come in unit dose blister packs of 10 tablets each. The rest of the text is not readable and may contain errors due to (Optical Character Recognition).*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 35 mg Blister Card - 4 Week Supply (4 Tablets) - risedronate fig11

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 35 mg Blister Card - 4 Week Supply (4 Tablets) - risedronate fig11

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 35 mg Blister Carton - 4 Week Supply (4 Tablets) - risedronate fig12

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 35 mg Blister Carton - 4 Week Supply (4 Tablets) - risedronate fig12

This text appears to be a set of instructions for taking risedronate sodium tablets. They advise taking the tablet once a week on the same day, in the morning with plain water, and not eating or drinking for thirty minutes afterward. They also instruct readers to store the tablets properly, keep them out of reach of children, and read the accompanying Medication Guide. The packaging is child-resistant and contains four tablets. The tablets contain risedronate sodium hemi-pentahydrate and have a usual adult dosage, which is not provided in the text.*

Figure 2 - risedronate fig2

Figure 2 - risedronate fig2

This appears to be a table with some headings and values, likely related to a study or research on bone mineral density and changes as measured by the mean percentage change (+ SE) in lumbar spine, femoral neck and femoral trochanter. However, without additional context, it is difficult to provide a more detailed description or analysis.*

Figure 3 - risedronate fig3

Figure 3 - risedronate fig3

The text is a table with headings related to a clinical trial, including the names of drugs tested (Placebo and Risedronate Sodium 5 mg), the number of participants (n=56 for each group), and three measurements taken (Lumbar Spine, Femoral Neck, and Femoral Trochanter). No further information is available.*

Figure 4 - risedronate fig4

Figure 4 - risedronate fig4

Figure 5 - risedronate fig5

Figure 5 - risedronate fig5

Figure 6 - risedronate fig6

Figure 6 - risedronate fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg (30 Tablet Bottle) - risedronate fig7

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg (30 Tablet Bottle) - risedronate fig7

This is a label for medication called Risedronate Sodium, with the drug code DG 65862-517-30. The medication comes in a bottle with 30 tablets. The label includes distribution information and dosage instructions, as well as precautions to store the medication between 20-25°C and away from children. There is also a warning not to take the medication without the prescription of a doctor.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg Blister Carton (10 x 10 Unit-dose) - risedronate fig8

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg Blister Carton (10 x 10 Unit-dose) - risedronate fig8

Risedronate Sodium Tablets, USP are available in blister packs. It is a prescription medication and a medication guide needs to be provided to each patient by the pharmacist. The NDC number is 65862-517-78. The rest of the text appears to be garbled and not available.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 30 mg (30 Tablet Bottle) - risedronate fig9

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 30 mg (30 Tablet Bottle) - risedronate fig9

This is a description of the medication Risedronate Sodium, which comes in tablets form and is available only with a prescription. Each film-coated tablet contains Risdronatesodium hem-pentahydrate USP equivalent to Risedronate sodium of 30 mg. It is distributed by Aurobindo Pharma USA, and the usual adult dosage can be found in the package insert. The medication should be stored at a temperature between 25°C to 120°C. The text also includes some printing codes but no useful information.*

Chemical Structure - risedronate str

Chemical Structure - risedronate str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.